- About Synapse
- How to Participate
- KAMJE Databases
- About Synapse
- How to Participate
- KAMJE Databases
- Home
- Journal List
- Cancer Res Treat
27 results
| 699 |
Editor’s Note on Recent Journal Impact Factor of Cancer Research and Treatment
Yong Chan Ahn
KMSID: 1516087907 Cancer Res Treat. 2024;56(3):699-699. Published online 2024 July 9 DOI: http://dx.doi.org/10.4143/crt.2024.619   | |
| 700 |
HER2-Low Breast Cancer: Now and in the Future
Sora Kang, Sung-Bae Kim
KMSID: 1516087884 Cancer Res Treat. 2024;56(3):700-720. Published online 2024 January 30 DOI: http://dx.doi.org/10.4143/crt.2023.1138 | |
| 721 |
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP
Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Shinkyo Yoon, Hyung-Don Kim, Inkeun Park, Jae Ho Jeong, Changhoon Yoo, Jaekyung Cheon, In-Ho Kim, Jieun Lee, Sook Hee Hong, Sehhoon Park, Hyun Ae Jung, Jin Won Kim, Han Jo Kim, Yongjun Cha, Sun Min Lim, Han Sang Kim, Choong-kun Lee, Jee Hung Kim, Sang Hoon Chun, Jina Yun, So Yeon Park, Hye Seung Lee, Yong Mee Cho, Soo Jeong Nam, Kiyong Na, Sun Och Yoon, Ahwon Lee, Kee-Taek Jang, Hongseok Yun, Sungyoung Lee, Jee Hyun Kim, Wan-Seop Kim
KMSID: 1516087882 Cancer Res Treat. 2024;56(3):721-742. Published online 2023 November 29 DOI: http://dx.doi.org/10.4143/crt.2023.1043 | |
| 743 |
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors
Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim, Baek-Yeol Ryoo, Jeong Eun Kim, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Werner, Sunil Sharma
KMSID: 1516087902 Cancer Res Treat. 2024;56(3):743-750. Published online 2024 January 18 DOI: http://dx.doi.org/10.4143/crt.2023.980  | |
| 751 |
Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan
KMSID: 1516087883 Cancer Res Treat. 2024;56(3):751-764. Published online 2024 January 2 DOI: http://dx.doi.org/10.4143/crt.2023.1118 | |
| 765 |
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer
Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, Hanseong Roh, Dongsoo Kyung, Hwang-Phill Kim, Duhee Bang, Bhumsuk Keam, Tae-Min Kim, Miso Kim, Dong-Wan Kim, Tae-You Kim
KMSID: 1516087895 Cancer Res Treat. 2024;56(3):765-773. Published online 2024 January 8 DOI: http://dx.doi.org/10.4143/crt.2023.1294 | |
| 774 |
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience
So Heun Lee, Hyehyun Jeong, Deok Hoon Kim, Se Jin Jang, Sang-We Kim, Shinkyo Yoon, Dae Ho Lee
KMSID: 1516087888 Cancer Res Treat. 2024;56(3):774-784. Published online 2024 January 30 DOI: http://dx.doi.org/10.4143/crt.2023.1177 | |
| 785 |
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer: Insights from Real-World Data
Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim
KMSID: 1516087881 Cancer Res Treat. 2024;56(3):785-794. Published online 2024 January 16 DOI: http://dx.doi.org/10.4143/crt.2023.1014 | |
| 795 |
Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study
Ruyan Zhang, Xiaoran Liu, Guohong Song, Yan Zhang, Huiping Li
KMSID: 1516087886 Cancer Res Treat. 2024;56(3):795-801. Published online 2023 December 20 DOI: http://dx.doi.org/10.4143/crt.2023.1151 | |
| 802 |
Implementation of BRCA Test among Young Breast Cancer Patients in South Korea: A Nationwide Cohort Study
Yung-Huyn Hwang, Tae-Kyung Yoo, Sae Byul Lee, Jisun Kim, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Il Yong Chung
KMSID: 1516087889 Cancer Res Treat. 2024;56(3):802-808. Published online 2024 February 19 DOI: http://dx.doi.org/10.4143/crt.2023.1186 | |
| 809 |
The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis
Jae-Uk Jeong, Chai Hong Rim, Gyu Sang Yoo, Won Kyung Cho, Eui Kyu Chie, Yong Chan Ahn, Jong Hoon Lee
KMSID: 1516087901 Cancer Res Treat. 2024;56(3):809-824. Published online 2023 December 14 DOI: http://dx.doi.org/10.4143/crt.2023.920 | |
| 825 |
The Persistence of Hypertriglyceridemia and the Risk of Early Onset Colorectal Cancer According to Tumor Subsites: A Nationwide Population-Based Study
Young Hoon Chang, Cheol Min Shin, Kyungdo Han, Jin Hyung Jung, Eun Hyo Jin, Joo Hyun Lim, Seung Joo Kang, Yoon Jin Choi, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
KMSID: 1516087898 Cancer Res Treat. 2024;56(3):825-837. Published online 2023 December 20 DOI: http://dx.doi.org/10.4143/crt.2023.753 | |
| 838 |
Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study
Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong
KMSID: 1516087899 Cancer Res Treat. 2024;56(3):838-846. Published online 2024 January 2 DOI: http://dx.doi.org/10.4143/crt.2023.886 | |
| 847 |
Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations
Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft
KMSID: 1516087890 Cancer Res Treat. 2024;56(3):847-855. Published online 2024 February 7 DOI: http://dx.doi.org/10.4143/crt.2023.1197 | |
| 856 |
Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic Strategy
Bokyung Ahn, Doeun Kim, Kye Jin Park, Ja-Min Park, Sun Young Yoon, Bumsik Hong, Yong Mee Cho, Deokhoon Kim
KMSID: 1516087885 Cancer Res Treat. 2024;56(3):856-870. Published online 2023 December 18 DOI: http://dx.doi.org/10.4143/crt.2023.1150 | |
| 871 |
Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study
Junho Lee, Sung Hee Lim, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park
KMSID: 1516087892 Cancer Res Treat. 2024;56(3):871-876. Published online 2024 January 16 DOI: http://dx.doi.org/10.4143/crt.2023.1226 | |
| 877 |
Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma
Jong Hoon Lee, Chung Un Lee, Jae Hoon Chung, Wan Song, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Hwan Sung
KMSID: 1516087893 Cancer Res Treat. 2024;56(3):877-884. Published online 2024 January 17 DOI: http://dx.doi.org/10.4143/crt.2023.1219 | |
| 885 |
Bilateral Seminal Vesicle Invasion as a Strong Prognostic Indicator in T3b Prostate Cancer Patients Following Radical Prostatectomy: A Comprehensive, Multicenter, Long-term Follow-up Study
Jungyo Suh, In Gab Jeong, Hwang Gyun Jeon, Chang Wook Jeong, Sangchul Lee, Seong Soo Jeon, Seok-Soo Byun, Cheol Kwak, Hanjong Ahn
KMSID: 1516087894 Cancer Res Treat. 2024;56(3):885-892. Published online 2024 January 5 DOI: http://dx.doi.org/10.4143/crt.2023.1264 | |
| 893 |
Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies
Sung Wook Cho, Sung Hee Lim, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park
KMSID: 1516087903 Cancer Res Treat. 2024;56(3):893-897. Published online 2024 February 15 DOI: http://dx.doi.org/10.4143/crt.2024.015 | |
| 898 |
Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
Kyeongmin Kwak, Seung-sik Hwang
KMSID: 1516087904 Cancer Res Treat. 2024;56(3):898-908. Published online 2024 January 15 DOI: http://dx.doi.org/10.4143/crt.2023.981 | |
| 909 |
The Role of Early and Delayed Surgery for Infants with Congenital Brain Tumors
Jong Seok Lee, Ji Yeoun Lee, Kyung Hyun Kim, Sung-Hye Park, Eun Jung Koh, Seung-Ki Kim, Ji Hoon Phi
KMSID: 1516087887 Cancer Res Treat. 2024;56(3):909-919. Published online 2023 December 28 DOI: http://dx.doi.org/10.4143/crt.2023.1174 | |
| 920 |
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim
KMSID: 1516087900 Cancer Res Treat. 2024;56(3):920-935. Published online 2024 January 16 DOI: http://dx.doi.org/10.4143/crt.2023.869 | |
| 936 |
Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study
Boyoung Park, Eunyoung Lee, Junghyun Yoon, YoungJu Park, Hyeon-Seok Eom
KMSID: 1516087897 Cancer Res Treat. 2024;56(3):936-944. Published online 2023 December 18 DOI: http://dx.doi.org/10.4143/crt.2023.843 | |
| 945 |
CD19-Specific CAR-T Cell Treatment of 115 Children and Young Adults with Acute B Lymphoblastic Leukemia: Long-term Follow-up
Yu Wang, Yu-juan Xue, Ying-xi Zuo, Yue-ping Jia, Ai-dong Lu, Hui-min Zeng, Le-ping Zhang
KMSID: 1516087891 Cancer Res Treat. 2024;56(3):945-955. Published online 2024 February 13 DOI: http://dx.doi.org/10.4143/crt.2023.1205 | |
| 956 |
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913)
Ho-Jin Shin, Do-Young Kim, Kihyun Kim, Chang-Ki Min, Je-Jung Lee, Yeung-Chul Mun, Won-Sik Lee, Sung-Nam Lim, Jin Seok Kim, Joon Ho Moon, Da Jung Kim, Soo-Mee Bang, Jong-Ho Won, Jae-Cheol Jo, Young Il Koh
KMSID: 1516087906 Cancer Res Treat. 2024;56(3):956-966. Published online 2024 March 4 DOI: http://dx.doi.org/10.4143/crt.2024.074 | |
| 967 |
Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series
Hyeon Gyu Kang, Jiwon Koh, Tae Min Kim, Doo Hee Han, Tae-Bin Won, Dong-Wan Kim, Dong-Young Kim, Bhumsuk Keam
KMSID: 1516087896 Cancer Res Treat. 2024;56(3):967-971. Published online 2024 February 13 DOI: http://dx.doi.org/10.4143/crt.2023.1308 | |
| 972 |
Bridging the Gap between Trial Adverse Events and Real-World Data
Sang Hyuk Kim, Hyun Lee, Dong Won Park
KMSID: 1516087905 Cancer Res Treat. 2024;56(3):972-973. Published online 2024 January 10 DOI: http://dx.doi.org/10.4143/crt.2024.019 | |